Sanofi pays $110M upfront for late-stage radioligand therapy, setting up rivalry with Novartis 0 12.09.2024 11:55 Fiercebiotech.com Sanofi pays $110M upfront for late-stage radioligand therapy, setting up rivalry with Novartis ntaylor Thu, 09/12/2024 - 04:55
